ATB — Antibiotice SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapFalling Star

Annual income statement for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	366	483	601	675	645
Cost of Revenue
Gross Profit	230	331	380	430	411
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	332	437	504	568	574
Operating Profit	34	45.7	96.5	107	71
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	30.3	41.9	91.5	103	60.1
Provision for Income Taxes
Net Income After Taxes	29.9	38.5	81.1	102	60.1
Net Income Before Extraordinary Items
Net Income	29.9	38.5	81.1	102	60.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29.9	38.5	81.1	102	60.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.045	0.057	0.123	0.152	0.09
Dividends per Share